Roll-over Study to Allow Continued Access to Ribociclib

Clinical trial NCT05161195 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT05161195
Sponsor: Novartis Pharmaceuticals
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 4
Study type: INTERVENTIONAL

Metastatic Breast Cancer

Start date: 2022-07-07
Primary completion: 2030-06-28
Enrollment: 134

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.